DJIA 17,658.14 61.79 0.35%
NASDAQ 4,984.43 25.96 0.52%
S&P 500 2,066.92 9.28 0.45%
market minute promo

Pfizer (NYSE: PFE)

33.52 -0.07 (-0.21%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PFE $33.52 -0.21%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $33.79
Previous Close $33.59
Daily Range $33.57 - $33.79
52-Week Range $27.51 - $35.53
Market Cap $206.4B
P/E Ratio 23.33
Dividend (Yield) $1.12 (3.3%)
Ex-Dividend Date
Dividend Pay Date
08/05/15
09/02/15
Volume 2,517,899
Average Daily Volume 22,377,299
Current FY EPS $2.03

Sector

Healthcare

Industry

Drug Makers

Pfizer (PFE) Description

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra. Website: http://www.pfizer.com/

News & Commentary

What Is Carl Icahn's Net Worth?

A look at the billionaire activist investor and hedge-fund manager, including some cautionary tales.

Roche's Multiple Sclerosis Studies Meet Primary Endpoint - Analyst Blog

Despite Recent Downgrade, This Ecommerce Giant is a Buy

Dow Movers: JPM, PFE

Premarket Biotech Digest: Trouble For Stryker Sub's Ex-CEO; Zoetis Merger Rumors

June 29 Premarket Biotech Digest: Trouble For Stryker Sub's Ex-CEO; Veracyte-Aetna Agreement; Zoetis

June 29 Premarket Biotech Digest: Trouble For Stryker Sub's Ex-CEO; Veracyte-Aetna Agreement; Zoetis Merger Rumors

Dow 30 Stock Roundup: Nike Beats Estimates, Verizon Closes AOL Buy - Analyst Blog

Zoetis Up as Valeant Rumored to be Interested in Buyout - Analyst Blog

Is Big Pharma Advertising Getting Out of Control?

Premarket Biotech Digest: Valent May Buy Zoetis, Medicines Co.'s Kengreal Approval, 2 New BMY Trials

Premarket Biotech Digest: Valent May Buy Zoetis, Medicines Co.'s Kengreal Approval, 2 New BMY Trials, Glaukos Jumps 70% Post IPO

See More PFE News...

PFE's Top Competitors

PFE $33.52 (-0.21%)
Current stock: PFE
JNJ $98.26 (0.59%)
Current stock: JNJ
ROG $66.71 (0.45%)
Current stock: ROG
GSK $42.01 (-0.05%)
Current stock: GSK